SAN FRANCISCO (PRWEB)
August 11, 2020

Cannformatics, an early stage biotech startup pioneering the use of metabolomics and AI to personalize medical cannabis treatments, today announced two new members to the company’s advisory board. The company welcomes nationally recognized board-certified emergency medicine physician Dr. Myiesha Taylor and University of California, San Francisco Assistant Professor Dr. Stephany Cox.

Dr. Taylor was recently named as one of Essence Magazine’s 50 Essential Heroes for her work in addressing COVID-19 healthcare disparities in underserved communities, she is also the inspiration behind Disney’s popular medical doctor character Doc McStuffins, for her work in championing black women around the world to pursue medical degrees.

Dr. Cox is a pediatric neuropsychologist whose expertise includes neurodevelopmental disorders such as autism spectrum disorder and attention deficit/hyperactivity disorder, she is also Co-Director of the UCSF Healthy Hearts and Minds Program.

Both Drs. Taylor and Cox will provide scientific review and high-level advice to Cannformatics’ management with regards to its upcoming autism pilot study as well as other R&D activities.

“Understanding cannabis’ impact on physiology and its connection to change in behavior is critical to removing stigma and creating broad acceptance of cannabis as a legitimate treatment option for the medical community,” said Cannformatics CEO Dr. Itzhak Kurek. “Cannformatics is at the forefront of identifying cannabis-responsive biomarkers found in saliva and applying them to personalized medical cannabis recommendations. Drs. Taylor and Cox joining our esteemed advisory board both deepens our scientific expertise as well as broadens the diversity of voices shaping our technology so that it can best serve all of the communities looking to medical cannabis to improve their health and quality of life.”

Share article on social media or email: